HFS
ENTA icon

HL Financial Services’s Enanta Pharmaceuticals ENTA Stock Holding History

HL Financial Services’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$4.28M Buy
44,849
+15
+0% +$1.35K 0.07% 186
2018
Q4 		$3.18M Sell
44,834
-451
-1% -$34.6K 0.06% 216
2018
Q3 		$3.87M Buy
+45,285
New +$4.54M 0.06% 196

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

HL Financial Services's ENTA Position: Q1 2019 in Review

HL Financial Services increased its Enanta Pharmaceuticals (ENTA) stake by 0.03% in Q1 2019, buying an estimated $1.35K and bringing the position to 44,849 shares worth $4.28M. The position accounts for 0.07% of the portfolio, ranked #186.

HL Financial Services first reported a position in ENTA in Q3 2018 and has held it in 3 quarters since. 195 funds tracked by Wall St. Rank hold ENTA as of Q1 2019.

  • HL Financial Services held 44,849 shares of Enanta Pharmaceuticals worth $4.28M as of Q1 2019.
  • HL Financial Services bought 15 Enanta Pharmaceuticals shares in Q1 2019, an estimated $1.35K.
  • Enanta Pharmaceuticals made up 0.07% of HL Financial Services's portfolio in Q1 2019, its #186 holding.
  • HL Financial Services first reported a position in Enanta Pharmaceuticals in Q3 2018 and has held it in 3 quarters since.
  • 195 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.